Literature DB >> 1967641

Multiple endocrine neoplasia type II B with symptoms suggesting Hirschsprung's disease: a case report.

S M Mahaffey1, L W Martin, A J McAdams, F C Ryckman, M Torres.   

Abstract

A 3-year-old child was referred with a tentative diagnosis of Hirschsprung's disease because of life-long constipation and "megacolon" demonstrated radiographically. Our rectal biopsy revealed hyperganglionosis suggestive of multiple endocrine neoplasia (MEN) type II B. This, in addition to an elevated serum calcitonin level, prompted surgical removal of her thyroid, which appeared grossly normal but on sectioning, contained a medullary carcinoma in each lobe. She remains disease-free 5 years later. Gastrointestinal symptoms are a significant component of the MEN type II B syndrome, and often antedate the full phenotypic expression of the syndrome and the development of potentially lethal endocrine neoplasms. On the basis of this experience, it is recommended that MEN II B be included in the differential diagnosis of chronic constipation.

Entities:  

Mesh:

Year:  1990        PMID: 1967641     DOI: 10.1016/s0022-3468(05)80172-1

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Gastrointestinal manifestations of multiple endocrine neoplasia type 2.

Authors:  Mark S Cohen; John E Phay; Charlotte Albinson; Mary K DeBenedetti; Michael A Skinner; Terry C Lairmore; Gerard M Doherty; Dennis M Balfe; Samuel A Wells; Jeffrey F Moley
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

2.  RET gene is a major risk factor for Hirschsprung's disease: a meta-analysis.

Authors:  C Tomuschat; P Puri
Journal:  Pediatr Surg Int       Date:  2015-07-12       Impact factor: 1.827

Review 3.  The genetic contribution to the phenotype.

Authors:  U Wolf
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

4.  Multiple endocrine neoplasia 2B presenting with pseudo-Hirschsprung's disease.

Authors:  Murat Faik Erdogan; Bulent Gulec; Alptekin Gursoy; Mesut Pekcan; Omer Azal; Omer Gunhan; Atilla Bayer
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.